Iron chelation therapy in patients with transfusion-dependent myelodysplastic syndrome

被引：3
|
作者：
Mast, Alan E. [1 ]
Field, Joshua J. [1 ]
机构：
[1] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA
来源：
TRANSFUSION | 2012年 / 52卷 / 10期
关键词：
BLOOD-DONORS; DEFICIENCY; GUIDELINES; STORES;
D O I：
10.1111/j.1537-2995.2012.03894.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2078 / 2080
页数：3
相关论文
共 50 条
  • [1] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
  • [2] Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients
    Oliva, Esther Natalie
    Ronco, Francesca
    Marino, Antonio
    Alati, Caterina
    Pratico, Giulia
    Nobile, Francesco
    [J]. TRANSFUSION, 2010, 50 (07) : 1568 - 1570
  • [3] Guidelines on iron chelation therapy in patients with myelodysplastic syndrome and transfusion iron overload
    Gattermann, N.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S15 - S16
  • [4] IRON CHELATION THERAPY IN TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE STUDY OF 53 PATIENTS IN A SINGLE INSTITUTION
    Finelli, C.
    Clissa, C.
    Barraco, M.
    De Maio, C.
    Fogli, M.
    Stanzani, M.
    Parisi, S.
    Paolini, S.
    Bosi, C.
    Cavo, M.
    [J]. HAEMATOLOGICA, 2017, 102 : 57 - 57
  • [5] IRON CHELATION THERAPY IMPROVES OXIDATIVE DNA DAMAGE IN HEMATOPOIETIC CELLS DERIVED FROM TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROME
    Kobune, Masayoshi
    Kikuchi, Shohei
    Iyama, Satoshi
    Takada, Kohichi
    Murase, Kazuyuki
    Ono, Kaoru
    Horiguchi, Hiroto
    Kamihara, Yusuke
    Hayashi, Tsuyoshi
    Sato, Tsutomu
    Miyanishi, Koji
    Sato, Yasushi
    Takimoto, Rishu
    Kato, Junji
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E98 - E98
  • [6] Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia
    Jamuar, Saumya S.
    Lai, Angeline H. M.
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (05) : 299 - 307
  • [7] Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy
    Pinto, Valeria
    Balocco, Manuela
    Ambaglio, Ilaria
    Derchi, Giorgio
    Malcovati, Luca
    Forni, Gian Luca
    [J]. CLINICAL CASE REPORTS, 2015, 3 (11): : 952 - 954
  • [8] Use of deferiprone for iron chelation in patients with transfusion-dependent thalassaemia
    Jamuar, Saumya Shekhar
    Lai, Angeline Hwei Meeng
    Tan, Ah Moy
    Chan, Mei Yoke
    Tan, Ee Shien
    Ng, Ivy Swee Lian
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2011, 47 (11) : 812 - 817
  • [9] A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients
    Theppornpitak, Krisada
    Trakarnsanga, Bussaba
    Lauhasurayotin, Supanun
    Poparn, Hansamon
    Chiengthong, Kanhatai
    Sosothikul, Darintr
    Techavichit, Piti
    [J]. HEMOGLOBIN, 2021, 45 (03) : 171 - 174
  • [10] Heterogeneity of myocardial iron distribution in response to chelation therapy in patients with transfusion-dependent anemias
    Hanneman, Kate
    Raju, Vikram M.
    Moshonov, Hadas
    Ward, Richard
    Wintersperger, Bernd J.
    Crean, Andrew M.
    Ross, Heather
    Nguyen, Elsie T.
    [J]. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2013, 29 (07): : 1517 - 1526
12345